This article provides a comprehensive analysis of sensitivity and specificity in emerging pathogen detection technologies, tailored for researchers, scientists, and drug development professionals.
This article provides a comprehensive overview of the transformative role of comparative genomic analysis in understanding and combating emerging pathogens.
This article provides a comprehensive analysis for researchers, scientists, and drug development professionals on the accuracy of phenotypic versus genotypic bacterial identification methods.
This article provides a systematic framework for researchers, scientists, and drug development professionals to validate the clinical significance of novel bacterial species.
This article addresses the critical challenges and limitations that automated diagnostic and surveillance systems face when confronting novel or unknown pathogens.
This article provides a comprehensive guide for researchers and drug development professionals seeking to enhance the sensitivity of pathogen detection assays.
Accurate bacterial genome identification is fundamental to clinical diagnostics, drug development, and public health, but its reliability is critically dependent on the reference databases used.
The viable but non-culturable (VBNC) state is a survival strategy adopted by numerous bacterial pathogens, allowing them to evade conventional culture-based detection, thereby posing a significant threat to food safety...
Cultivating fastidious bacteria remains a significant challenge in clinical microbiology and drug development, often hindering pathogen identification, antibiotic susceptibility testing, and biomedical research.
This article explores the transformative convergence of advanced microscopy, microfluidics, and artificial intelligence in bacterial detection and identification.